Table 1.

Local vascular volumes (μl (g dry wt)⁻¹); 30 min albumin clearances (μl (g dry wt)⁻¹); normalized albumin clearances and water content (ml (g dry wt)⁻¹) in skin and muscle

	Vehicle	ANP	Rolipram	Rolipram + ANP
Vascular volume
Back skin	9.0 ± 0.8	8.9 ± 0.8	9.4 ± 1.4	10.5 ± 1.1
Hamstring muscle	22.9 ± 1.1	20.1 ± 0.8	23.0 ± 0.9	24.0 ± 1.5
Quadriceps muscle	16.1 ± 0.9	14.0 ± 0.8	19.9 ± 0.92	17.3 ± 1.4
Clearance
Back skin	15.8 ± 1.8	36.1 ± 5.81	9.5 ± 1.32	13.3 ± 1.42
Hamstring muscle	11.3 ± 1.0	14.1 ± 1.1	8.5 ± 0.82	8.6 ± 0.62
Quadriceps muscle	9.2 ± 0.6	11.9 ± 1.01	6.4 ± 1.62	6.9 ± 0.52
Normalized clearance
Back skin	1.91 ± 0.24	4.02 ± 0.531	1.06 ± 0.102	1.39 ± 0.152
Hamstring muscle	0.52 ± 0.05	0.72 ± 0.061	0.38 ± 0.042	0.37 ± 0.032
Quadriceps muscle	0.64 ± 0.06	0.91 ± 0.091	0.34 ± 0.032	0.46 ± 0.052
Water content
Back skin	1.79 ± 0.12	1.86 ± 0.13	1.83 ± 0.14	1.88 ± 0.12
Hamstring muscle	4.01 ± 0.08	3.93 ± 0.05	3.92 ± 0.11	3.88 ± 0.07
Quadriceps muscle	4.07 ± 0.04	4.16 ± 0.05	4.14 ± 0.16	4.14 ± 0.13

P < 0.05:

¹when compared to Control;

²when compared to ANP; Means ± SEM.